annual CFF:
$5.13B+$14.54B(+154.45%)Summary
- As of today (May 29, 2025), BMY annual cash flow from financing activities is $5.13 billion, with the most recent change of +$14.54 billion (+154.45%) on December 31, 2024.
- During the last 3 years, BMY annual CFF has risen by +$21.35 billion (+131.60%).
- BMY annual CFF is now -32.73% below its all-time high of $7.62 billion, reached on December 31, 2019.
Performance
BMY Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$993.00M+$649.00M(+39.52%)Summary
- As of today (May 29, 2025), BMY quarterly cash flow from financing activities is -$993.00 million, with the most recent change of +$649.00 million (+39.52%) on March 31, 2025.
- Over the past year, BMY quarterly CFF has dropped by -$15.64 billion (-106.78%).
- BMY quarterly CFF is now -105.44% below its all-time high of $18.27 billion, reached on June 30, 2019.
Performance
BMY quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$10.51B-$15.64B(-304.99%)Summary
- As of today (May 29, 2025), BMY TTM cash flow from financing activities is -$10.51 billion, with the most recent change of -$15.64 billion (-304.99%) on March 31, 2025.
- Over the past year, BMY TTM CFF has dropped by -$18.79 billion (-226.96%).
- BMY TTM CFF is now -170.34% below its all-time high of $14.94 billion, reached on June 30, 2019.
Performance
BMY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BMY Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +154.4% | -106.8% | -227.0% |
| 3 y3 years | +131.6% | +82.4% | +27.9% |
| 5 y5 years | -32.7% | +5.8% | -222.3% |
BMY Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +130.2% | -106.8% | +82.4% | -227.0% | +40.6% |
| 5 y | 5-year | -32.7% | +130.2% | -106.8% | +86.4% | -222.3% | +40.6% |
| alltime | all time | -32.7% | +130.2% | -105.4% | +87.1% | -170.3% | +40.6% |
BMY Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$993.00M(-39.5%) | -$10.51B(-305.0%) |
| Dec 2024 | $5.13B(-154.4%) | -$1.64B(-57.4%) | $5.13B(-33.7%) |
| Sep 2024 | - | -$3.85B(-4.3%) | $7.74B(+20.3%) |
| Jun 2024 | - | -$4.02B(-127.5%) | $6.43B(-22.3%) |
| Mar 2024 | - | $14.64B(+1414.4%) | $8.28B(-187.9%) |
| Dec 2023 | -$9.42B(-44.5%) | $967.00M(-118.7%) | -$9.42B(-30.9%) |
| Sep 2023 | - | -$5.16B(+137.5%) | -$13.63B(+4.7%) |
| Jun 2023 | - | -$2.17B(-28.8%) | -$13.01B(-9.4%) |
| Mar 2023 | - | -$3.05B(-6.0%) | -$14.36B(-15.3%) |
| Dec 2022 | -$16.96B(+4.5%) | -$3.25B(-28.5%) | -$16.96B(-4.1%) |
| Sep 2022 | - | -$4.54B(+29.1%) | -$17.68B(+18.5%) |
| Jun 2022 | - | -$3.52B(-37.7%) | -$14.92B(+2.3%) |
| Mar 2022 | - | -$5.65B(+42.5%) | -$14.58B(-10.1%) |
| Dec 2021 | -$16.22B(+1309.6%) | -$3.97B(+122.9%) | -$16.22B(+84.9%) |
| Sep 2021 | - | -$1.78B(-44.1%) | -$8.77B(-8.4%) |
| Jun 2021 | - | -$3.18B(-56.4%) | -$9.58B(+29.6%) |
| Mar 2021 | - | -$7.29B(-309.4%) | -$7.39B(+542.2%) |
| Dec 2020 | -$1.15B(-115.1%) | $3.48B(-234.6%) | -$1.15B(-90.7%) |
| Sep 2020 | - | -$2.59B(+160.5%) | -$12.31B(+15.4%) |
| Jun 2020 | - | -$993.00M(-5.8%) | -$10.66B(-224.1%) |
| Mar 2020 | - | -$1.05B(-86.3%) | $8.60B(+12.8%) |
| Dec 2019 | $7.62B(-315.6%) | -$7.68B(+715.8%) | $7.62B(-48.2%) |
| Sep 2019 | - | -$941.00M(-105.2%) | $14.72B(-1.5%) |
| Jun 2019 | - | $18.27B(-1000.3%) | $14.94B(-444.1%) |
| Mar 2019 | - | -$2.03B(+251.0%) | -$4.34B(+22.8%) |
| Dec 2018 | -$3.54B(-13.3%) | -$578.00M(-19.7%) | -$3.54B(-18.0%) |
| Sep 2018 | - | -$720.00M(-29.1%) | -$4.31B(+0.3%) |
| Jun 2018 | - | -$1.01B(-16.9%) | -$4.29B(+0.2%) |
| Mar 2018 | - | -$1.22B(-9.6%) | -$4.29B(+5.1%) |
| Dec 2017 | -$4.08B(+53.7%) | -$1.35B(+91.5%) | -$4.08B(+22.4%) |
| Sep 2017 | - | -$706.00M(-29.8%) | -$3.33B(+5.0%) |
| Jun 2017 | - | -$1.01B(-0.7%) | -$3.17B(+16.7%) |
| Mar 2017 | - | -$1.01B(+67.4%) | -$2.72B(+2.4%) |
| Dec 2016 | -$2.65B(-26.8%) | -$605.00M(+10.8%) | -$2.65B(-22.1%) |
| Sep 2016 | - | -$546.00M(-1.1%) | -$3.41B(-4.3%) |
| Jun 2016 | - | -$552.00M(-41.9%) | -$3.56B(-8.5%) |
| Mar 2016 | - | -$950.00M(-30.1%) | -$3.89B(+7.4%) |
| Dec 2015 | -$3.62B(+48.7%) | -$1.36B(+94.1%) | -$3.62B(+45.2%) |
| Sep 2015 | - | -$700.00M(-20.7%) | -$2.50B(+7.4%) |
| Jun 2015 | - | -$883.00M(+29.5%) | -$2.32B(+20.6%) |
| Mar 2015 | - | -$682.00M(+195.2%) | -$1.93B(-20.9%) |
| Dec 2014 | -$2.44B(+128.2%) | -$231.00M(-56.3%) | -$2.44B(+63.0%) |
| Sep 2014 | - | -$528.00M(+8.6%) | -$1.50B(-5.8%) |
| Jun 2014 | - | -$486.00M(-59.2%) | -$1.59B(-28.4%) |
| Mar 2014 | - | -$1.19B(-267.7%) | -$2.22B(+107.5%) |
| Dec 2013 | -$1.07B(-75.4%) | $711.00M(-214.7%) | -$1.07B(-61.0%) |
| Sep 2013 | - | -$620.00M(-44.4%) | -$2.74B(-28.1%) |
| Jun 2013 | - | -$1.11B(+2434.1%) | -$3.81B(+7.5%) |
| Mar 2013 | - | -$44.00M(-95.4%) | -$3.54B(-18.3%) |
| Dec 2012 | -$4.33B(+63.1%) | -$958.00M(-43.3%) | -$4.33B(+4.9%) |
| Sep 2012 | - | -$1.69B(+98.7%) | -$4.13B(+31.3%) |
| Jun 2012 | - | -$850.00M(+1.7%) | -$3.14B(+12.2%) |
| Mar 2012 | - | -$836.00M(+10.9%) | -$2.80B(+5.4%) |
| Dec 2011 | -$2.66B(-20.5%) | -$754.00M(+7.1%) | -$2.66B(-25.5%) |
| Sep 2011 | - | -$704.00M(+38.9%) | -$3.57B(+0.2%) |
| Jun 2011 | - | -$507.00M(-26.7%) | -$3.56B(+0.3%) |
| Mar 2011 | - | -$692.00M(-58.4%) | -$3.55B(+6.2%) |
| Dec 2010 | -$3.34B(>+9900.0%) | -$1.66B(+138.4%) | -$3.34B(+388.0%) |
| Sep 2010 | - | -$698.00M(+41.0%) | -$685.00M(+6.5%) |
| Jun 2010 | - | -$495.00M(+1.9%) | -$643.00M(-25.1%) |
| Mar 2010 | - | -$486.00M(-148.9%) | -$858.00M(+4947.1%) |
| Dec 2009 | -$17.00M(-99.3%) | $994.00M(-251.5%) | -$17.00M(-98.9%) |
| Sep 2009 | - | -$656.00M(-7.6%) | -$1.61B(-49.1%) |
| Jun 2009 | - | -$710.00M(-300.0%) | -$3.17B(+112.5%) |
| Mar 2009 | - | $355.00M(-158.9%) | -$1.49B(-42.2%) |
| Dec 2008 | -$2.58B(-19.6%) | -$603.00M(-72.8%) | -$2.58B(+3.2%) |
| Sep 2008 | - | -$2.21B(-328.5%) | -$2.50B(+17.3%) |
| Jun 2008 | - | $969.00M(-232.0%) | -$2.13B(-36.6%) |
| Mar 2008 | - | -$734.00M(+40.1%) | -$3.37B(+4.8%) |
| Dec 2007 | -$3.21B | -$524.00M(-71.6%) | -$3.21B(-28.0%) |
| Sep 2007 | - | -$1.84B(+598.5%) | -$4.46B(+38.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$264.00M(-54.6%) | -$3.22B(-9.1%) |
| Mar 2007 | - | -$581.00M(-67.3%) | -$3.55B(+5.8%) |
| Dec 2006 | -$3.35B(-7.9%) | -$1.77B(+193.9%) | -$3.35B(-988.9%) |
| Sep 2006 | - | -$604.00M(+2.9%) | $377.00M(-19.1%) |
| Jun 2006 | - | -$587.00M(+52.5%) | $466.00M(-123.9%) |
| Mar 2006 | - | -$385.00M(-119.7%) | -$1.95B(-46.4%) |
| Dec 2005 | -$3.64B(+685.5%) | $1.95B(-479.2%) | -$3.64B(-38.9%) |
| Sep 2005 | - | -$515.00M(-82.8%) | -$5.96B(+11.7%) |
| Jun 2005 | - | -$3.00B(+44.7%) | -$5.33B(+100.6%) |
| Mar 2005 | - | -$2.07B(+466.7%) | -$2.66B(+473.9%) |
| Dec 2004 | -$463.00M(-55.1%) | -$366.00M(-432.7%) | -$463.00M(-21.5%) |
| Sep 2004 | - | $110.00M(-133.6%) | -$590.00M(-25.5%) |
| Jun 2004 | - | -$327.00M(-372.5%) | -$792.00M(-41.6%) |
| Mar 2004 | - | $120.00M(-124.3%) | -$1.36B(+31.5%) |
| Dec 2003 | -$1.03B(-7.7%) | -$493.00M(+435.9%) | -$1.03B(+107.0%) |
| Sep 2003 | - | -$92.00M(-89.7%) | -$498.00M(-50.6%) |
| Jun 2003 | - | -$891.00M(-300.2%) | -$1.01B(+330.8%) |
| Mar 2003 | - | $445.00M(+1012.5%) | -$234.00M(-79.1%) |
| Dec 2002 | -$1.12B(-163.2%) | $40.00M(-106.6%) | -$1.12B(-68.0%) |
| Sep 2002 | - | -$602.00M(+414.5%) | -$3.49B(-202.0%) |
| Jun 2002 | - | -$117.00M(-73.3%) | $3.42B(+39.5%) |
| Mar 2002 | - | -$438.00M(-81.3%) | $2.45B(+38.8%) |
| Dec 2001 | $1.77B(-142.5%) | -$2.34B(-137.0%) | $1.77B(-42.2%) |
| Sep 2001 | - | $6.32B(-681.0%) | $3.06B(-171.9%) |
| Jun 2001 | - | -$1.09B(-3.3%) | -$4.25B(+0.5%) |
| Mar 2001 | - | -$1.12B(+7.5%) | -$4.23B(+1.8%) |
| Dec 2000 | -$4.16B(+40.8%) | -$1.05B(+4.8%) | -$4.16B(+2.6%) |
| Sep 2000 | - | -$998.00M(-6.2%) | -$4.05B(+11.7%) |
| Jun 2000 | - | -$1.06B(+1.4%) | -$3.63B(+13.6%) |
| Mar 2000 | - | -$1.05B(+11.4%) | -$3.19B(+8.2%) |
| Dec 1999 | -$2.95B(+11.7%) | -$942.00M(+64.1%) | -$2.95B(+33.6%) |
| Sep 1999 | - | -$574.00M(-8.9%) | -$2.21B(-2.0%) |
| Jun 1999 | - | -$630.00M(-21.8%) | -$2.25B(-14.5%) |
| Mar 1999 | - | -$806.00M(+305.0%) | -$2.64B(-0.2%) |
| Dec 1998 | -$2.64B(+22.8%) | -$199.00M(-67.9%) | -$2.64B(-14.7%) |
| Sep 1998 | - | -$620.00M(-38.7%) | -$3.10B(+6.3%) |
| Jun 1998 | - | -$1.01B(+24.5%) | -$2.91B(+14.5%) |
| Mar 1998 | - | -$812.00M(+24.3%) | -$2.54B(+18.3%) |
| Dec 1997 | -$2.15B(+14.1%) | -$653.00M(+49.4%) | -$2.15B(+21.2%) |
| Sep 1997 | - | -$437.00M(-31.9%) | -$1.77B(+2.7%) |
| Jun 1997 | - | -$642.00M(+53.2%) | -$1.73B(+4.0%) |
| Mar 1997 | - | -$419.00M(+51.3%) | -$1.66B(-11.8%) |
| Dec 1996 | -$1.89B(+1.4%) | -$277.00M(-29.2%) | -$1.89B(-9.9%) |
| Sep 1996 | - | -$391.00M(-32.0%) | -$2.09B(-11.4%) |
| Jun 1996 | - | -$575.00M(-10.4%) | -$2.36B(+10.4%) |
| Mar 1996 | - | -$642.00M(+32.9%) | -$2.14B(+15.0%) |
| Dec 1995 | -$1.86B(+13.4%) | -$483.00M(-26.9%) | -$1.86B(-6.3%) |
| Sep 1995 | - | -$661.00M(+87.8%) | -$1.99B(+53.8%) |
| Jun 1995 | - | -$352.00M(-3.0%) | -$1.29B(-16.2%) |
| Mar 1995 | - | -$363.00M(-40.4%) | -$1.54B(-6.0%) |
| Dec 1994 | -$1.64B(-3.6%) | -$609.00M(-1945.5%) | -$1.64B(+5.3%) |
| Sep 1994 | - | $33.00M(-105.5%) | -$1.56B(-28.1%) |
| Jun 1994 | - | -$602.00M(+30.6%) | -$2.17B(+28.2%) |
| Mar 1994 | - | -$461.00M(-12.5%) | -$1.69B(-0.6%) |
| Dec 1993 | -$1.70B(-2.7%) | -$527.00M(-8.5%) | -$1.70B(+10.1%) |
| Sep 1993 | - | -$576.00M(+360.8%) | -$1.54B(+16.8%) |
| Jun 1993 | - | -$125.00M(-73.5%) | -$1.32B(-20.9%) |
| Mar 1993 | - | -$472.00M(+27.2%) | -$1.67B(-4.4%) |
| Dec 1992 | -$1.75B(+10.8%) | -$371.00M(+4.8%) | -$1.75B(-2.1%) |
| Sep 1992 | - | -$354.00M(-25.3%) | -$1.78B(+1.5%) |
| Jun 1992 | - | -$474.00M(-13.7%) | -$1.76B(+9.9%) |
| Mar 1992 | - | -$549.00M(+34.6%) | -$1.60B(+1.5%) |
| Dec 1991 | -$1.58B(+5.6%) | -$408.00M(+24.8%) | -$1.58B(+1.9%) |
| Sep 1991 | - | -$327.00M(+3.5%) | -$1.55B(-8.6%) |
| Jun 1991 | - | -$316.00M(-39.9%) | -$1.69B(-0.9%) |
| Mar 1991 | - | -$526.00M(+38.8%) | -$1.71B(+14.5%) |
| Dec 1990 | -$1.49B(+48.2%) | -$379.00M(-19.9%) | -$1.49B(+34.0%) |
| Sep 1990 | - | -$473.00M(+42.5%) | -$1.11B(+73.7%) |
| Jun 1990 | - | -$332.00M(+7.1%) | -$642.00M(+107.1%) |
| Mar 1990 | - | -$310.00M | -$310.00M |
| Dec 1989 | -$1.01B | - | - |
FAQ
- What is Bristol-Myers Squibb annual cash flow from financing activities?
- What is the all time high annual CFF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual CFF year-on-year change?
- What is Bristol-Myers Squibb quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly CFF year-on-year change?
- What is Bristol-Myers Squibb TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM CFF year-on-year change?
What is Bristol-Myers Squibb annual cash flow from financing activities?
The current annual CFF of BMY is $5.13B
What is the all time high annual CFF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual cash flow from financing activities is $7.62B
What is Bristol-Myers Squibb annual CFF year-on-year change?
Over the past year, BMY annual cash flow from financing activities has changed by +$14.54B (+154.45%)
What is Bristol-Myers Squibb quarterly cash flow from financing activities?
The current quarterly CFF of BMY is -$993.00M
What is the all time high quarterly CFF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly cash flow from financing activities is $18.27B
What is Bristol-Myers Squibb quarterly CFF year-on-year change?
Over the past year, BMY quarterly cash flow from financing activities has changed by -$15.64B (-106.78%)
What is Bristol-Myers Squibb TTM cash flow from financing activities?
The current TTM CFF of BMY is -$10.51B
What is the all time high TTM CFF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM cash flow from financing activities is $14.94B
What is Bristol-Myers Squibb TTM CFF year-on-year change?
Over the past year, BMY TTM cash flow from financing activities has changed by -$18.79B (-226.96%)